Literature DB >> 11519733

Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity.

V Calabrese1, G Scapagnini, A M Giuffrida Stella, T E Bates, J B Clark.   

Abstract

It is becoming increasingly evident that the mitochondrial genome may play a key role in neurodegenerative diseases. Mitochondrial dysfunction is characteristic of several neurodegenerative disorders, and evidence for mitochondria being a site of damage in neurodegenerative disorders is partially based on decreases in respiratory chain complex activities in Parkinson's disease, Alzheimer's disease, and Huntington's disease. Such defects in respiratory complex activities, possibly associated with oxidant/antioxidant balance perturbation, are thought to underlie defects in energy metabolism and induce cellular degeneration. Efficient functioning of maintenance and repair process seems to be crucial for both survival and physical quality of life. This is accomplished by a complex network of the so-called longevity assurance processes, which are composed of genes termed vitagenes. A promising approach for the identification of critical gerontogenic processes is represented by the hormesis-like positive effect of stress. In the present review, we discuss the role of energy thresholds in brain mitochondria and their implications in neurodegeneration. We then review the evidence for the role of oxidative stress in modulating the effects of mitochondrial DNA mutations on brain age-related disorders and also discuss new approaches for investigating the mechanisms of lifetime survival and longevity.

Entities:  

Mesh:

Year:  2001        PMID: 11519733     DOI: 10.1023/a:1010955807739

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  174 in total

1.  A case of severe hypermetabolism of nonthyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study.

Authors:  R LUFT; D IKKOS; G PALMIERI; L ERNSTER; B AFZELIUS
Journal:  J Clin Invest       Date:  1962-09       Impact factor: 14.808

2.  Oxidative stress and apoptosis.

Authors: 
Journal:  Pathophysiology       Date:  2000-09

Review 3.  Mitochondrial aging: open questions.

Authors:  K B Beckman; B N Ames
Journal:  Ann N Y Acad Sci       Date:  1998-11-20       Impact factor: 5.691

4.  Regulation of cytochrome c oxidase and FoF1-ATPase subunits expression in rat brain during aging.

Authors:  V G Nicoletti; E A Tendi; A Console; A Privitera; R F Villa; N Ragusa; A M Giuffrida-Stella
Journal:  Neurochem Res       Date:  1998-01       Impact factor: 3.996

5.  Free radical theory of aging: dietary implications.

Authors:  D Harman
Journal:  Am J Clin Nutr       Date:  1972-08       Impact factor: 7.045

6.  Huntington's disease progression. PET and clinical observations.

Authors:  T C Andrews; R A Weeks; N Turjanski; R N Gunn; L H Watkins; B Sahakian; J R Hodges; A E Rosser; N W Wood; D J Brooks
Journal:  Brain       Date:  1999-12       Impact factor: 13.501

7.  Nitric-oxide-induced inhibition of glyceraldehyde-3-phosphate dehydrogenase may mediate reduced endothelial cell monolayer integrity in an in vitro model blood-brain barrier.

Authors:  R D Hurst; S Azam; A Hurst; J B Clark
Journal:  Brain Res       Date:  2001-03-16       Impact factor: 3.252

8.  Neurotoxic Abeta peptides increase oxidative stress in vivo through NMDA-receptor and nitric-oxide-synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro.

Authors:  J K Parks; T S Smith; P A Trimmer; J P Bennett; W D Parker
Journal:  J Neurochem       Date:  2001-02       Impact factor: 5.372

9.  Reversible effects of long-term caloric restriction on protein oxidative damage.

Authors:  M J Forster; B H Sohal; R S Sohal
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2000-11       Impact factor: 6.053

10.  Intense oxidative DNA damage promoted by L-dopa and its metabolites. Implications for neurodegenerative disease.

Authors:  J P Spencer; A Jenner; O I Aruoma; P J Evans; H Kaur; D T Dexter; P Jenner; A J Lees; D C Marsden; B Halliwell
Journal:  FEBS Lett       Date:  1994-10-24       Impact factor: 4.124

View more
  74 in total

Review 1.  Mitochondrial function in apoptotic neuronal cell death.

Authors:  Samantha L Budd Haeberlein
Journal:  Neurochem Res       Date:  2004-03       Impact factor: 3.996

2.  Administration of memantine and imipramine alters mitochondrial respiratory chain and creatine kinase activities in rat brain.

Authors:  Gislaine Z Réus; Roberto B Stringari; Gislaine T Rezin; Daiane B Fraga; Juliana F Daufenbach; Giselli Scaini; Joana Benedet; Natália Rochi; Emílio L Streck; João Quevedo
Journal:  J Neural Transm (Vienna)       Date:  2011-09-28       Impact factor: 3.575

3.  Protective effect of carnosine during nitrosative stress in astroglial cell cultures.

Authors:  V Calabrese; C Colombrita; E Guagliano; M Sapienza; A Ravagna; V Cardile; G Scapagnini; A M Santoro; A Mangiameli; D A Butterfield; A M Giuffrida Stella; E Rizzarelli
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

Review 4.  Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?

Authors:  Kawser Akter; Emily A Lanza; Stephen A Martin; Natalie Myronyuk; Melanie Rua; Robert B Raffa
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

5.  Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription.

Authors:  Marcus J Calkins; Rebekah J Jakel; Delinda A Johnson; Kaimin Chan; Yuet Wai Kan; Jeffrey A Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-20       Impact factor: 11.205

Review 6.  Oxidative stress in schizophrenia: an integrated approach.

Authors:  Byron K Y Bitanihirwe; Tsung-Ung W Woo
Journal:  Neurosci Biobehav Rev       Date:  2010-10-23       Impact factor: 8.989

7.  Human skeletal muscle mitochondrial metabolism in youth and senescence: no signs of functional changes in ATP formation and mitochondrial oxidative capacity.

Authors:  Ulla F Rasmussen; Peter Krustrup; Michael Kjaer; Hans N Rasmussen
Journal:  Pflugers Arch       Date:  2003-03-05       Impact factor: 3.657

Review 8.  Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration.

Authors:  Juan A Orellana; Pablo J Sáez; Kenji F Shoji; Kurt A Schalper; Nicolás Palacios-Prado; Victoria Velarde; Christian Giaume; Michael V L Bennett; Juan C Sáez
Journal:  Antioxid Redox Signal       Date:  2009-02       Impact factor: 8.401

9.  Brain mitochondrial lipid abnormalities in mice susceptible to spontaneous gliomas.

Authors:  Michael A Kiebish; Xianlin Han; Hua Cheng; Jeffrey H Chuang; Thomas N Seyfried
Journal:  Lipids       Date:  2008-06-17       Impact factor: 1.880

10.  Protective effect of verbascoside in activated C6 glioma cells: possible molecular mechanisms.

Authors:  Emanuela Esposito; Roberto Dal Toso; Giovanna Pressi; Placido Bramanti; Rosaria Meli; Salvatore Cuzzocrea
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-11-11       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.